Kei Tomihara

10PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 15, 2026
Mechanisms Underlying Negative p53 Immunocytochemistry in Oral Cytology: TP53 mRNA Expression and Sampling Limitations.

|Jan 18, 2026
A case of Stevens-Johnson syndrome triggered by Mycoplasma infection.

Atsushi Uenoyama, Hideaki Hirai, Yuko Saito

|Dec 30, 2025
High CD36 Expression Predicts Aggressive Invasion and Recurrence in Oral Squamous Cell Carcinoma.

Kotaro Sakurai, Kei Tomihara, Manabu Yamazaki

|Oct 26, 2024
Development and Characterization of a Three-Dimensional Organotypic In Vitro Oral Cancer Model with Four Co-Cultured Cell Types, Including Patient-Derived Cancer-Associated Fibroblasts.

Yuka Aizawa, Kenta Haga, Nagako Yoshiba

|Sep 14, 2024
Targeting CD36-Mediated Lipid Metabolism by Selective Inhibitor-Augmented Antitumor Immune Responses in Oral Cancer.

Mayu Takaichi, Hidetake Tachinami, Danki Takatsuka

|May 25, 2024
Rapamycin Induces Phenotypic Alterations in Oral Cancer Cells That May Facilitate Antitumor T Cell Responses.

Amirmoezz Yonesi, Kei Tomihara, Danki Takatsuka

Pageof 2

Frequent Collaborators

5 joint publications

Jun-Ichi Tanuma

4 joint publications

Manabu Yamazaki

2 joint publications

Hidetake Tachinami

2 joint publications

Kumiko Fujiwara